{"schema_version":1,"assessment_id":"eoa_inverse_innovation_exp03_opportunity320_20260801","source_experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"layer_decay_and_expiration_management__chemistry_materials","archetype_slug":"layer_decay_and_expiration_management","domain_slug":"chemistry_materials","title":"Validity-Gated Retention and Reversible Disposition for Aging Material Samples","opportunity_summary":"Establish sample-level validity, dependency, retention, and lifecycle states so suspect materials leave routine selection, storage can be tiered, and disposal follows dependency review and reversible quarantine. The candidate could reduce misleading reuse, storage burden, and unmanaged risk while preserving provenance, but the frequency of these harms, stakeholder demand, effect magnitude, and distinctiveness are unverified.","adopter_authorizer":"The laboratory manager can authorize visibility changes and storage tiering. Irreversible disposal additionally requires the sample owner or delegated scientific custodian and, where hazard rules apply, EHS approval; investigation and compliance holds override disposal.","scores":{"meaningful_impact":{"score":4,"rationale":"Preventing invalid-sample reuse and preserving unique evidence could materially improve experimental reliability, safety, and storage utilization. The score is limited because the sealed candidate provides no measured prevalence, baseline loss rate, or effect size."},"stakeholder_pull":{"score":2,"rationale":"Researchers, laboratory managers, sample owners, and EHS personnel are identifiable beneficiaries, but the packet contains no interviews, adoption requests, capacity data, incident history, or demonstrated willingness to change workflows."},"incremental_advantage":{"score":3,"rationale":"Compared with the stated fixed-date LIMS rival, the proposal adds measured-condition gaps, validity gating, dependency review, tiering, reversible quarantine, and restore drills. Whether these additions outperform configurable existing practice enough to justify their burden is untested."},"distinctiveness_plausibility":{"score":2,"rationale":"The composition is coherent, but prior art is explicitly unsearched and overlapping practice may exist in LIMS, chemical inventory, specimen governance, biobanking, or archival sample management. Distinctiveness therefore lacks an affirmative evidentiary basis."},"technical_implementability":{"score":4,"rationale":"A bounded implementation can use inventory records, labels, rules, access controls, condition checks, quarantine, and audit logs without requiring speculative science. Identity resolution, material-specific validation, hazardous handling, and legacy metadata quality remain material constraints."},"adoption_authority_feasibility":{"score":4,"rationale":"The candidate names laboratory-manager, scientific-custodian, and EHS authority, preserves holds, excludes automatic destruction, and supplies halt and rollback rules. Cross-owner dependencies and local compliance requirements could still delay decisions."},"evidence_readiness":{"score":4,"rationale":"The packet defines a safe pilot of at most 200 samples, relevant outcomes, separate problem and intervention falsifiers, a stratified condition check, a 5% classification-error halt threshold, and quarantine without destruction. Measurement definitions and a rigorous concurrent comparison still require specification."},"safety_net_benefit":{"score":5,"rationale":"The intervention specifically removes suspect samples from ordinary selection while retaining reversibility through quarantine, dependency review, recorded authority, holds, audit history, and restoration to prior custody and metadata state. It also explicitly avoids claiming chemical restoration."},"scalability":{"score":3,"rationale":"The register-and-rules model could extend across storage units and laboratories, but scaling requires material-specific aging logic, lineage cleanup, dependency resolution, quarantine capacity, system integration, and repeated scientific and EHS review."}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"10K_TO_50K","scope":"One review cycle covering at most 200 samples in one storage unit, including inventory reconciliation, labeling, metadata setup, EHS planning, stratified condition checks, quarantine handling, and outcome analysis.","confidence":"MODERATE","assumptions":["Existing controlled storage and basic inventory tooling are available.","Only a subset receives laboratory condition testing.","No hazardous container is opened or moved outside approved controls.","No irreversible disposal occurs."]},"initial_deployment_startup":{"band_2026_usd":"50K_TO_250K","scope":"Preparation for use across one materials laboratory, including legacy-data reconciliation, lifecycle-rule design, LIMS or register configuration, access controls, SOPs, training, audit design, and quarantine-space preparation.","confidence":"LOW","assumptions":["The laboratory can configure an existing system rather than procure and build a new enterprise platform.","Sample identities are imperfect but substantially recoverable.","Material-specific rules require scientific review but not extensive new degradation research.","Facility modifications remain minor."]},"operational_launch":{"band_2026_usd":"50K_TO_250K","scope":"Initial operational review and transition of a laboratory collection, including sample triage, dependency outreach, approved moves, condition testing, exception adjudication, tier reassignment, and launch evaluation.","confidence":"LOW","assumptions":["Collection size is limited to a single laboratory rather than an institution-wide archive.","Most samples can be handled using existing laboratory controls.","Testing is stratified rather than universal.","Quarantine capacity is available or can be added without major construction."]},"annual_recurring":{"band_2026_usd":"50K_TO_250K","scope":"Ongoing ownership review, metadata maintenance, periodic revalidation, condition testing, restore drills, EHS oversight, storage-tier management, exception handling, software support, and audit reporting for one laboratory.","confidence":"LOW","assumptions":["Review is risk-tiered and periodic rather than continuous.","Existing laboratory and EHS staff absorb part of the workflow.","No unusually large regulated or cryogenic collection is included.","Assay consumption and specialized preservation needs remain limited."]}},"research_burden":"MODERATE","earliest_credible_horizon":"0_TO_3_MONTHS","pipeline_gates":{"recognizable_externally_supportable_problem":{"status":"YES","reason":"The candidate specifies recognizable mechanisms—oxidation, moisture uptake, phase change, contamination, and container degradation—and concrete consequences involving validity, storage, safety, provenance, and reproducibility. Their local frequency and magnitude still require measurement."},"identifiable_adopter_or_authorizer":{"status":"YES","reason":"The laboratory manager is identified for visibility and storage decisions, while the sample owner or scientific custodian and EHS are identified for irreversible disposition, subject to overriding holds."},"distinct_testable_incremental_claim":{"status":"YES","reason":"The proposal claims that validity gating, dependency review, controlled tiering, and reversible quarantine improve on passive storage or fixed discard dates by reducing overdue or superseded sample selection and active-tier occupancy without unacceptable retrieval delay, error, incidents, or specimen loss."},"bounded_next_evidence_step":{"status":"YES","reason":"The authorized pilot is capped at 200 samples in one storage unit for one review cycle, uses stratified condition checks, forbids destruction, and includes explicit halt and rollback conditions."},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"Hazardous handling requires approved controls; incompatible consolidation, automatic destruction, and hold overrides are excluded. Unexpected degradation, unsafe conditions, unresolved dependencies, or excessive classification error trigger a halt and restoration of custody and metadata state."},"implementation_cost_scope_and_range":{"status":"UNCERTAIN","reason":"The pilot population is bounded, but the packet does not specify collection scale, staff time, assay types, existing system capability, metadata quality, quarantine capacity, or facility changes needed for broader implementation; cost ranges therefore depend heavily on assumptions."}},"blocking_evidence":["A blinded baseline audit establishing whether condition uncertainty, mistaken reuse, storage burden, or reconstruction loss occurs at decision-relevant frequency.","Condition-check results establishing the precision and false-stale rate of the proposed rules, including performance for old but unique specimens.","Comparative pilot evidence that validity gating reduces selection of overdue or superseded samples or active-tier occupancy without unacceptable retrieval delay, safety events, or loss of needed specimens.","Confirmation that sample identities, lineage, owners, external dependencies, and applicable holds can be resolved sufficiently for safe decisions.","Evidence that suitable quarantine capacity and material-compatible handling controls are available.","Prior-art comparison against LIMS configuration, chemical inventory controls, specimen or biobank governance, and archival sample-management practice."],"next_evidence_step":"Run the authorized one-cycle pilot on no more than 200 samples in one storage unit. First conduct a blinded baseline audit and stratified condition checks, then compare validity-gated selection and tiering with the unit's existing selection process on overdue or superseded selections, active-tier occupancy, retrieval time, classification error, safety events, and requests for quarantined specimens. Quarantine but do not destroy; falsify or halt the intervention if benefits are absent, any safety incident or needed-specimen loss occurs, or more than 5% of reviewed samples are wrongly classified as stale.","research_questions":["How often are samples selected as representative despite unresolved condition or validation status?","Which age, storage-history, container, and material-class signals predict measured condition without treating age itself as invalidity?","What false-stale and false-current rates result from the proposed classification rules?","How many samples have unresolved ownership, lineage, external dependencies, or holds?","Does gating reduce mistaken selection and active-tier occupancy relative to current practice without materially increasing retrieval delay?","How much compatible quarantine and lower-tier storage capacity is available?","Which sample classes require prompt destruction rather than quarantine because of instability or regulation?","How frequently do quarantined samples need restoration for reproducibility, investigation, or collaboration?","Can an existing LIMS or chemical inventory system implement the composition without substantial custom development?","Which elements are already present in laboratory, biobank, specimen-governance, chemical-inventory, or archival practice?"] ,"recommendation":"PRIOR_ART_RESEARCH","uncertainty_constraints":["Closed-book assessment provides no evidence of problem prevalence, market size, realized impact, or stakeholder demand.","Prior art is unsearched, so novelty and defensible distinctiveness cannot be inferred.","Material-specific degradation rates and reliable staleness predictors are hypotheses.","Cost bands are resource-equivalent estimates based on assumed laboratory scale, tooling, testing intensity, and quarantine capacity.","Physical aging and destructive assays limit reversibility; rollback restores custody and metadata state, not chemical condition.","Informal dependencies, unique specimens, hazardous containers, and regulated materials may constrain or prevent disposition."],"closed_book_prior_art_boundary":"No conclusion is made about novelty, prevalence, or competitive uniqueness. The sealed packet identifies a nearest conceptual rival but supplies no search results; laboratory information systems, chemical inventory controls, biobank or specimen governance, and archival sample-management practices must be examined externally before any originality claim."}